Biogen (BIIB) Restructuring Costs (2010 - 2026)

Biogen's Restructuring Costs history runs 13 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• In Q1 2026, Restructuring Costs fell 77.62% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $21.2 million (down 60.74% YoY), while the FY2025 annual figure was $48.6 million, up 60.93% from the prior year.
• Restructuring Costs was $7.9 million for Q1 2026 at Biogen, up from $6.6 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $900.0 million in Q2 2022 to a low of -$700000.0 in Q2 2025.
• Historically, Restructuring Costs has averaged $68.5 million across 5 years, with a median of $7.4 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Restructuring Costs soared 1311.43% in 2023, then slumped 110.61% in 2025.
• A 5-year view of Restructuring Costs shows it stood at $7.0 million in 2022, then jumped by 1311.43% to $98.8 million in 2023, then sank by 94.64% to $5.3 million in 2024, then gained by 24.53% to $6.6 million in 2025, then advanced by 19.7% to $7.9 million in 2026.
• The last three Restructuring Costs figures came in at $7.9 million (Q1 2026), $6.6 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.